Banco Bilbao Vizcaya Argentaria, S.A. Aldeyra Therapeutics, Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.0 - $7.53 $1.26 Million - $2.36 Million	-313,889 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.97 - $5.05 $519,861 - $1.33 Million	263,889 Added 527.78%	313,889 $1.31 Million
Q1 2020 May 13, 2020	BUY	$1.62 - $6.4 $48,600 - $192,000	30,000 Added 150.0%	50,000 $123,000
Q4 2019 Feb 13, 2020	BUY	$4.73 - $7.98 $94,600 - $159,600	20,000 New	20,000 $116,000

128

37.6M

757K

539K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $390M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.